Business · 1 sources covering this

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

The lawsuits target a range of businesses that allegedly marketed ⁠retatrutide products to consumers despite the drug remaining under clinical development.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·2h ago
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
The lawsuits target a range of businesses that allegedly marketed ⁠retatrutide products to consumers despite the drug remaining under clinical development.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/b9c9ba756a0f995f8e90753543616217660d697a"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide"></iframe>

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

How 1 sources are covering this

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

More from Business

Chinese tech giant Tencent posts revenue beat on accelerating games sales, AI-driven ads

CPI report shows inflation eased in July to a 3.4% annual pace

Here’s what to know about the report.

CoreWeave surges 20% in premarket after a 'cleaner quarter.' Here's what's happening

Reader

Trust & legal

Across the network